| Model Name | Pragmatic-Explanatory Continuum Indicator Summary 2 |
D and/or I | D=I |
| Construct Flexibility | 5 |
| Socio-Ecological Levels | Individual
Organization
Community
System
|
| Figure | No figure is associated with this model. |
| Field of Origin | Health Services Research |
| Practioner/Researcher | Researcher |
| Constructs | Adopter/implementer/decision maker characteristics
Compatibility
Context - Inner setting
Evaluation
Innovation characteristics
Outcomes - Health/QOL/Satisfaction/Clinical
|
| Website | https://www.precis-2.org/
|
| Number of Times Cited | 413 |
| Citations | Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose BMJ 2015;350:h2147
PRECIS-2 website
https://www.precis-2.org/
Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009;62:464-75.
Loudon K, Zwarenstein M, Sullivan F, et al. Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose. Trials 2013;14:115.
|
| Examples | Forbes G, Loudon K, Treweek S, Taylor SJC, Eldridge S. Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2. J Clin Epidemiol. 2017 Oct;90:119-126.
Lipman PD, Loudon K, Dluzak L, Moloney R, Messner D, Stoney CM. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains. Trials. 2017 Nov 10;18(1):532.
Zwarenstein M, Howie A. Blinding, pragmatism, and the PRECIS-2 tool for designing and assessing randomized trials. Eur J Clin Pharmacol. 2021 Jan 4. doi: 10.1007/s00228-020-03078-6.
Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015 May 8;350:h2147. doi: 10.1136/bmj.h2147.
|